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Observations and Research
Barriers to Psychosocial Support and Quality 
of Life for Patients With Inflammatory Bowel 
Disease: A Survey Study
Rebecca Lawrence, MD* and Cuckoo Choudhary, MD*,†
Background: Psychological comorbidities are common among people with inflammatory bowel disease (IBD) and are associated with worse 
disease outcomes. Evidence-based psychotherapy is an effective means to increase psychosocial support. This study aimed to identify the barriers 
to attending psychotherapy.
Methods: This electronic survey study included a demographic, quality of life, and barriers to psychotherapy questionnaire. Quality of life 
was assessed using the Short Inflammatory Bowel Disease Questionnaire (SIBDQ). Barriers were assessed using the Perceived Barriers to 
Psychological Treatments scale (PBPT). Linear regression was used to identify participant characteristics associated with higher PBPT scores.
Results: One hundred eighty-seven participants completed the study. Fifty-eight percent of participants had ≥1 significant barrier. Time (28%), 
knowledge about the availability of services (25%), and cost (19%) were the most common barriers. Least common were stigma (14%), lack of 
motivation (12%), and emotional concerns (7%). Lower SIBDQ scores, being male, not being full-time employed, having Crohn disease, and 
being in disease remission were associated with higher PBPT scores.
Conclusions: Knowledge about the availability of services, time constraints, and cost are the leading barriers to psychotherapy among people 
with IBD. Care providers should develop a network of psychotherapists available to those with IBD. Being male and not being full-time employed 
may be risk factors for greater barriers. Further research is needed on barriers among groups underrepresented in this study and on novel psycho-
therapy solutions, like telehealth and low-cost options.
Lay Summary
Mental illnesses can make inflammatory bowel disease worse. Psychotherapy can help. This study looked at the reasons why people do not go to 
psychotherapy. Time, awareness, and cost were most common. Stigma and motivation were least common.
Key Words:  IBD, quality of life, barrier, psychotherapy
INTRODUCTION
Inflammatory bowel disease (IBD) is a complex, chronic 
disease that impacts the psychosocial elements of people’s 
lives. Psychiatric conditions are colloquially described as an 
extraintestinal manifestation of IBD.1 People with IBD have 
psychological illnesses, particularly depression and anxiety, at 
rates almost twice that of the general population.2 Having psy-
chological comorbidities are associated with worse disease out-
comes including increased hospitalizations, disease severity, rates 
of surgery, and reliance upon medication for disease control.3,4
Many studies and initiatives have called for increased 
attention to the psychological health of  people with IBD.1,5,6 
Several studies have explored coping strategies and psycho-
social interventions. Adaptive coping strategies, like using 
support systems and directly addressing a problem, are as-
sociated with better disease outcomes and higher quality of 
life.7,8 Additionally, people have been found to benefit from 
interventions that increase psychosocial support.9 People 
with IBD tend to value psychotherapy over medications 
for psychological healthcare.6 However, even when recom-
mended, most people do not initiate psychological therapy.10 
Given the increased risk for psychosocial comorbidities and 
the potential benefit toward quality of  life and disease out-
come, it is worth investigating the barriers to psychoso-
cial support among people with IBD. Identifying the most 
common barriers to psychosocial support and the demo-
graphic or health characteristics associated with greater 
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barriers will allow providers to more effectively counsel and 
coordinate care for people who suffer from the psychosocial 
effects of IBD.
This study has 3 aims:
 1. Identify the barriers to mental healthcare among people with IBD.
 2. Assess the relationships among barriers to mental healthcare, 
quality of life, and demographic and health characteristics in people 
with IBD.




This study involved an electronic survey. Eligible parti-
cipants were identified by reviewing the patients seen over a 
6-month period at 2 urban Gastroenterology & Hepatology 
clinics. Eligibility criteria included having IBD diagnosed by a 
gastroenterologist, being at least 18 years of age, being English 
literate, and having an email address listed in the medical re-
cords. Once identified, potential participants were sent an email 
that contained a brief  explanation of the study, an electronic 
consent form, and the survey through the “survey monkey” 
website. A second and third follow-up email were sent within 
a month of the initial survey invitation if  the participant had 
not completed the survey. This investigational study aimed to 
enroll ≥160 participants based on previous research with similar 
measures.11
Ethical Considerations
The study protocol was refined and approved by the 
Institutional Review Board. All subjects provided an elec-
tronic consent. The survey was completed anonymously. The 
“survey monkey” web service has features that enable anony-
mous tracking of  responses. The anonymous tracking enabled 
study personnel to determine which participants had not com-
pleted the survey and needed a follow-up email per the study 
protocol.
Electronic Survey
Demographics, quality of life, and barriers to psychoso-
cial support were measured through 3 sequential questionnaires.
 1. Demographics questionnaire: Demographic and health history 
information was collected through a demographic survey. The in-
formation gathered included participant age, sex, ethnicity, mar-
ital status, diagnosis, number years since diagnosis, current disease 
status, family history of IBD, time in flare-up (%), surgery for IBD, 
employment status, and level of education.
 2. Quality of life questionnaire: Quality of life was measured through 
the Short Inflammatory Bowel Disease Questionnaire (SIBDQ), a 
validated 10 item 7-point Likert scale survey designed specifically 
for people with IBD. It addresses the intestinal, systemic, emo-
tional, and social aspects of quality of life.12 Scores range from 10 
to 70 where higher scores indicate higher quality of life. A 9-point 
score difference was considered a clinically meaningful difference.13
 3. Barriers to psychosocial support questionnaire: Barriers to psy-
chosocial support was evaluated with the Perceived Barriers to 
Psychological Treatments scale (PBPT). The PBPT is a validated 
25 item survey that encompasses 8 subscales to address different 
types of barriers: stigma (7 items), motivation (2 items), emotional 
concerns (3 items), negative evaluations of therapy (4 items), misfit 
of therapy to needs (4 items), time constraints (2 items), partici-
pation restriction (4 items), and availability of services (2 items). 
Four items cross over categories. One item investigates cost which is 
not factored in to a subscale score. The questionnaire ends with an 
open-ended question to provide comments. The PBPT scale demon-
strated strong predictive validity.14,15
Each item on the scale presents a situation where parti-
cipants answer the extent to which the situation would hinder 
their ability to pursue counseling. For example, participants 
would fill in the statement “Getting time off work to go to coun-
seling would make it _____ for me to attend weekly counseling.” 
Answer options are on a 5-point Likert scale where 5 = impos-
sible, 4 = extremely difficult, 3 = moderately difficult, 2 = slightly 
difficult, and 1  =  not difficult at all. Both dichotomous and 
summed scoring methods are used. The dichotomous scoring in-
terprets a response of a 4 or 5 as perceiving a significant barrier 
for that item. This method aligns with prior research suggesting 
that noting 1 significant barrier may be enough to prevent at-
tending therapy. A total summed score is calculated by adding 
the numeric answers of each item to yield a total score ranging 
from 25 to 125. This method reflects the summation effect of bar-
riers, where when more barriers are perceived the less likely the 
participant will be to attend counseling.14,15
Statistical Analysis
Cronbach’s alpha was calculated for each of the scales to 
assess internal validity. Descriptive characteristics were calcu-
lated for all items on the demographic questionnaire. For the 
first aim of identifying the perceived barriers, the PBPT results 
were viewed dichotomously. The percentage of participants 
who answered with a 4 or 5 for each item on the PBPT was 
reported to quantify the frequency of a barrier. The subscale 
frequencies are standardized by averaging the percentages for 
each item in the subscale.
The second aim of assessing the relationship between 
perceived barriers, demographic and health characteristics, 
and SIBDQ scores was evaluated using summed PBPT scores. 
Linear regression was used to compare summed PBPT scores 
with demographic and health characteristics and SIBDQ scores. 
Comparisons were made with both the total and subscale PBPT 
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RESULTS
Study Population
Eight hundred seventy-nine (879) eligible patients were 
contacted, 210 participants consented, and 187 completed all 
questions. Table 1 presents the characteristics of the study pop-
ulation. Participants were 62% female, 89% Caucasian, and 
59% in disease remission with 41% in a flare at the time of study 
completion.
Internal Validity
Table 2 presents the Cronbach’s alpha for each scale. The 
Cronbach’s alpha for the SIBDQ was 0.81. The Cronbach’s 
alpha for the PBPT was 0.92 and all 8 subscales had a 
Cronbach’s alpha ≥0.75.
Aim 1—Identifying Barriers
Table 3 presents the frequency of choosing at least 1 sig-
nificant barrier overall, on each subscale, and on each ques-
tion. The summed scores for each subscale and total score for 
the PBPT are presented for comparison. 58% of participants 
cited having at least 1 significant barrier. Availability of services 
(25%) and time (28%) were most frequently cited as a signifi-
cant barrier. Least reported as barriers were stigma (14%), lack 
of motivation (12%), and emotional concerns (7%).
Aim 2—Assessing the Relationship Between 
Barriers and Participant Characteristics
The associations between participant characteristics and 
summed PBPT scores are presented in Table 4 for total score 
and Table 5 for subscale scores. Higher SIBDQ scores were as-
sociated with lower summed PBPT scores for the total score 
and for all 8 subscale scores. The inverse relationship between 
SIBDQ scores and total summed PBPT scores has an R2 of 0.22 
(Fig. 1). Males compared to females had higher PBPT scores 
for the total score and on the misfit of needs, participation re-
strictions, and availability of services subscales. Not being em-
ployed full-time compared to being full-time employed was 
associated with higher PBPT scores on the total score and on 
the stigma, emotional, negative evaluation of therapy, time, and 
participation restriction subscales. Having Crohn disease com-
pared to having ulcerative colitis/other colitis was associated 
with higher PBPT scores on the total score and on the stigma, 
emotional, time, and participation restriction subscales. Having 
disease in remission compared to having a flare was associated 
with higher PBPT scores on the total score and on the emo-
tional and availability subscales.
Participant characteristics that were not significantly 
associated with summed PBPT scores include age, race, mar-
ital status, having a family history of  IBD, years since di-
agnosis, the percent of  time in a flare-up, and having had 
surgery for IBD.
TABLE 1. Characteristics of Study Population
Age (y), mean (SD) 46 (17)
Sex, n (%)
 Female 116 62%
 Male 71 38%
Race/ethnicity, n (%)
 Caucasian 167 89%
 African American 6 3%
 Latino/Hispanic 7 4%
 Asian 5 3%
 Middle Eastern 1 1%
 Indian/Other 1 1%
Marital status, n (%)
 Single/never married 52 28%
 Married/partnered 119 64%
 Separated/divorced 11 6%
 Widowed 4 2%
Education, n (%)
 Less than high school 2 1%
 Completed high school 31 17%
 Completed college 81 43%
 Schooling beyond college 73 39%
Employment status, n (%)
 Student 14 8%
 Unemployed 12 6%
 Part time 14 8%
 Full time 111 60%
 Retired 35 19%
Family history of IBD, n (%)
 No 121 65%
 Yes 65 35%
Diagnosis, n (%)
 Crohn disease 96 51%
 Ulcerative colitis 76 41%
 Other colitis 15 8%
Time since diagnosis (y), mean (SD) 16 (14)
Current disease status, n (%)
 In remission 110 59%
 Active/flaring 77 41%
Time in flare-up, n (%)
 Rarely (0%–25%) 76 41%
 Sometimes (26%–50%) 61 33%
 Often (51%–76%) 26 14%
 Most of the time (76%–100%) 23 12%
Surgery for IBD, n (%)
 No 133 71%
 Yes 54 29%
Quality of life score (SIBDQ), mean (SD) 48 (12)
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There were 59 optional free response comments sub-
mitted. They were categorized as a suggestion (2), an 
elaboration on barriers (40), study feedback (4), and non-
contributory (16), with 3 comments overlapping categories. 
Suggestions offered include proposing an IBD-specific coun-
selor where “knowledge about the disease would be benefi-
cial to the counseling relationship” and at-home counseling 
sessions.
DISCUSSION
Psychological disorders are a common comorbidity 
among people with IBD that negatively impact quality of  life. 
While psychotherapy has been shown to be a valued and effec-
tive treatment, people do not always pursue the therapy. This 
study sought to identify the barriers to psychotherapy. The 
study also aimed to identify relationships between barriers 
and demographical and health characteristics. This knowl-
edge will help providers to use valuable patient care time more 
effectively.
Barriers Among Patients With IBD
This is the first study that has used the PBPT scale 
among patients with IBD. The internal validity of  the PBPT 
in the present study was acceptable-excellent. The first aim 
was successfully completed. The percentage of  participants 
identifying at least 1 significant barrier was 58%. This result is 
similar to a previous study in a non-IBD population where the 
author’s found that 55% of  participants identified at least 1 
significant barrier.14 The previous study also found that when 
comparing participants with and without depression, the rate 
of  identifying at least 1 significant barrier increased to 78% 
from 49% in patients with depression.14 It is possible that a 
similar rate increase among people with depression exists in 
the IBD population.
TABLE 3. Summary of Reported Barriers
Total PBPT score (25–125), mean (SD) 43 (14)
 Total # significant barriers,* median  
 (interquartile range)
1 (3)
 Significant barrier present,* n (%) 109 58%
Stigma
 Subscale score (7–35), mean (SD) 10 (4.1)
 Significant barrier present,* n (%) 25 14%
   20 Discomfort with having someone  
 see me while I am emotional
8 4%
   22 Having family and/or friends know  
 I was going to counseling
6 3%
   23 Having to talk to someone I do not  
 know about personal issues
7 4%
   24 My concern about being judged by  
 the counselor
6 3%
   25 I do not think a counselor would  
 not truly care about me
9 5%
   26 Attending counseling means  
 I cannot solve my own problems
7 4%




 Subscale score (2–10), mean (SD) 3.7 (1.8)
 Significant barrier present,* n (%) 22 12%
  18 Lack of energy or motivation 18 10%
   19 Difficulty motivating myself  to do  
 anything at all
13 7%
Emotional concerns
 Subscale score (3–15), mean (SD) 4.5 (2.1)
 Significant barrier present,* n (%) 14 7%
   16 Concerns about having upsetting  
 feelings in counseling
5 3%
   17 I feel that talking about upsetting  
 issues makes them worse
8 4%
   20 Discomfort with having someone see 
 me while I am emotional
8 4%
Negative evaluation of therapy
 Subscale score (4–20), mean (SD) 6.7 (3.3)
 Significant barrier present,* n (%) 36 19%
   11 Having heard about or having bad  
 or unsatisfactory experiences with  
 counseling
9 5%
  12 Distrust of counsellors 20 11%
   13 I wouldn’t expect counseling to  
 be helpful
19 10%
   25 I do not think a counselor would  
 not truly care about me
9 5%
Misfit of therapy to needs
 Subscale score (4–20), mean (SD) 6.7 (3.1)
 Significant barrier present,* n (%) 33 18%
   13 I wouldn’t expect counseling to be helpful 19 10%
   14 Attending counseling is too  
 self-indulgent
13 7%
TABLE 2. Scale Reliability






Negative evaluation of therapy 4 0.83
Misfit of needs 4 0.77
Time 5 0.75
Participation restrictions 4 0.77
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The leading barriers identified in the present study 
were time constraints and availability of  services. Time con-
straints have been found to be particularly predictive of  fol-
lowing up with psychotherapy.14 While it did not qualify for 
its own subscale, the item that assessed cost barriers was 
the item most frequently endorsed as a barrier. Cost has 
also been cited as the greatest barrier in other research.14,16 
Interestingly, stigma was not endorsed as a significant bar-
rier. This differs from a prior study among people with de-
pression where stigma in addition to cost and knowledge 
about how to find help (availability of  services) were leading 
barriers.16 The present study suggests that people with IBD 
share the barriers of  cost, time, and a lack knowledge about 
availability of  services but do not share the stigma barrier 
with people who do not have IBD.
The second aim of the study was to investigate the re-
lationship between barriers, participant characteristics, and 
quality of life. Quality of life was found to have an inverse 






Age (y) −1 (−2.3, 0.4) 0.165
 <30 47 (14)   
 30–39 42 (12)   
 40–59 42 (13)   
 60+ 41 (17)   
Sex
 Female 42 (12)   
 Male 44 (17) 4.4 (0.6, 8.2) 0.025
Race/ethnicity
 Caucasian 42 (13)   
 Non-Caucasian 47 (18) 3.1 (−3.0, 9.2) 0.313
Marital status
 Married/partnered 41 (13)   
 Single/divorced/widowed 46 (15) 1.6 (−2.5, 5.6) 0.445
Education 0.575
 High school or less 47 (16)   
 College 43 (15) −0.4 (−5.4, 4.7) 0.889
 Graduate 40 (12) −2.2 (−7.4, 3.0) 0.401
Employment status
 Full time 42 (11)   
 Not full time 45 (17) 4.9 (1.0, 8.9) 0.014
Family history of IBD
 No 43 (14)   
 Yes 44 (13) 3.2 (−0.5, 6.9) 0.091
Diagnosis
 Crohn disease 45 (14)   
 Ulcerative colitis/other colitis 41 (13) −6.3 (−10.6, −2.0) 0.004
Time since diagnosis (y)
 ≤10 44 (15)   
 >10 41 (13) −0.5 (−2.2, 1.1) 0.537
Current disease status
 In remission 41 (14)   
 Active/flaring 45 (14) −5.8 (−10.4, −1.3) 0.013
Time in flare-up 0.148
 Rarely (0%–25%) 38 (11)   
 Sometimes (26%–50%) 47 (14) 4.6 (−0.2, 9.5) 0.060
 Often/most of the time (>50%) 45 (16) 2.2 (−4.1, 8.4) 0.497
Surgery for IBD
 No 43 (15)   
 Yes 42 (11) −3.3 (−8.1, 1.5) 0.176
Quality of life score (SIBDQ) −5.8 (−7.7, −3.9) 0.001
 7–40 51 (15)   
 41–50 42 (13)   
 51+ 38 (11)   
CI, confidence interval.
Mean difference for age and time since diagnosis of IBD refers to a 10-year difference; 
mean difference for the total SIBDQ score refers to a 10-point difference.
   21 My problems are not severe enough  
 for counseling
17 9%
   26 Attending counseling means  
 I cannot solve my own problems
7 4%
Time constraints
 Subscale score (2–10), mean (SD) 4.7 (2.1)
 Significant barrier present,* n (%) 53 28%
   4 My daily responsibilities and  
 activities
39 21%




 Subscale score (4–20), mean (SD) 6.1 (2.8)
 Significant barrier present,* n (%) 34 18%
   1 Problems with transportation (no car/ 
 parking, poor public transportation,  
 etc.)
19 10%
   8 Physical problems (such as difficulties 
 walking or getting around)
4 2%
   9 Physical symptoms (fatigue, pain,  
 breathing difficulties, etc.)
6 3%
   10 Serious illness which requires me to  
 stay close to home
19 10%
Availability of services
 Subscale score (2–10), mean (SD) 4.4 (2.1)
 Significant barrier present,* n (%) 46 25%
   5 The lack of available counseling  
 services in my area
23 12%




 3 The cost of counseling 35 19%
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relationship with the perception of barriers. This consistent 
correlation may be because some of the factors that enhance 
quality of life, like overall disease severity, are also the ones 
that reduce barriers.13 Other characteristics associated with in-
creased barriers were being male, not being full-time employed, 
having Crohn disease, and having disease in remission. Despite 
the small subgroup sample sizes, the consistent significant as-
sociation in the overall and subscale scores affirms that partici-
pants with these particular characteristics may be at increased 
risk of perceiving greater barriers. There was not a consistent 
association between perceived barriers and age, race, relation-
ship status, level of education, time since diagnosis, family his-
tory of IBD, percent of time in flare-up, or prior surgeries for 
IBD. These results differ from prior research in the non-IBD 
population that found higher total PBPT scores among non-
Caucasian participants, participants without partners, and 
younger participants and no difference in total PBPT score 
based on gender.14
Evaluation of Study
The study has several limitations. First, the sample size 
does not allow for sufficiently powered subgroup analysis. 
Modest though important differences in significant subscale 
categories and participant characteristics may have been be 
overlooked. When significant results were found in the sub-
group and subscale analyses, caution was taken to empha-
size only the consistent, significant trends in the discussion. 
Additionally, the present study does not account for preexisting 
psychiatric conditions. The survey initially included a question 
on psychiatric history but eliminated the data as the survey 
format does not ensure the accurate or complete collection of 
psychiatric history. In future research it may be worthwhile in-
cluding a question of psychiatric conditions as well as a Patient 
Health Questionnaire (PHQ). A PHQ scores have been used in 
prior research using the PBPT.4,14,15 A PHQ score would help 
explore how depression severity and mood symptoms affect 
perceived barriers.3,6
Another limitation is that the survey did not inquire about 
current or past psychotherapy experiences. This was omitted 
as the PBPT accounts for the influence of past psychotherapy 
experiences (item 11 displayed in Table 2). Further, the PBPT 
scale has been found to have strong predictive validity.14,15 Other 
limitations include a sampling bias where only patients with an 
email listed in their electronic medical record were contacted 
and a participation bias favoring those intrigued by the topic 
of mental health and IBD. Additionally, the demographic and 
health characteristics of the participants are unevenly distrib-
uted being predominantly made up of Caucasians, females, full-
time workers, people in a relationship, and those who received 
higher education. Individuals from groups less represented in 
this study may be at increased risk of having greater perceived 
barriers.
An important strength of the study was that it was entirely 
anonymous. Providing personal information regarding psycho-
logical and gastrointestinal illnesses relative to other illnesses 
may cause participants to feel particularly vulnerable and re-
luctant to share honest information. The electronic survey al-
lowed the study to be conducted while maintaining anonymity. 
Further, participants were able to complete the survey in the 
location of their choosing, allowing for privacy. Additionally, 
the internal validity of the survey questions was optimized by 
the use of unmodified, validated questionnaires.
Suggestions for Reducing Barriers to 
Psychotherapy
The third and final aim of this study is to provide institu-
tional suggestions on ways to reduce barriers to mental health-
care. First, knowing the characteristics associated with having 
barriers and knowing what the most common barriers are al-
lows providers to identify at-risk patients and plan their visits 
accordingly. The present study suggests that males and those 
not full-time employed, among others, may be at increased risk 
of perceiving greater barriers. Regarding the most common 
barriers, the availability of services barrier is based on people 
perceiving a lack of available counseling services in the area and 
not knowing how to find a good counselor (2 items from the 
PBPT). Patients would benefit from their care provider helping 
them to navigate the services available. To enhance this process, 
a gastroenterology office can establish a network of reliable 
therapists. Referring patients to a therapist already trusted 
and with experience working with people with IBD would al-
leviate this barrier—and address the suggestion offered by one 
of the participants. To establish this network, providers can 
learn about resources from patients who have had successful 
therapist relationships, consult with colleagues in other depart-
ments who have found a trusted therapist or reliable network, 
FIGURE 1. SIBDQ scores are inversely proportional to PBPT scores. 
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create a behavioral health team for their department by hiring 
therapists with experience and interest caring for patients with 
gastrointestinal illnesses, provide resources such as weblinks or 
pamphlets to patients to help them search for a therapist whose 
practice aligns with their needs regarding hours of availability, 
location, and telehealth capabilities.
For people who travel further distances for their care, 
telehealth psychotherapy visits may help to decrease this bar-
rier. Telehealth psychotherapy has been found to be no less ef-
fective than non-telehealth psychotherapy for depression.17 The 
barrier of having time constraints could also be in part minim-
ized by telehealth services.
When it comes to the cost barrier, solutions are more dif-
ficult. Informal, low cost, or free online discussion groups and 
other resources for support exist, but there is currently no evi-
dence on how they affect disease outcomes or quality of life.18 
Like other formal, long-term therapies, people rely on their 
health insurance to help cover costs. The different healthcare 
plans cover mental health support to various extents, but all 
leave a burden on the patient and limit the availability of serv-
ices. Increasing the number of psychotherapists familiar with 
caring for people with IBD, providing telehealth psychotherapy, 
and diminishing costs of psychotherapy and mental healthcare 
services all rely on changes in the healthcare system at large. This 
study starts to elicit those changes by identifying their need.
CONCLUSIONS
This is the first study to identify the perceived barriers 
to psychotherapy among the IBD population and to delineate 
associated demographic or health characteristics of people who 
are at an increased risk of perceiving greater barriers. Cost, 
time restraints, and the availability of services were found to 
be the leading perceived barriers. Additionally, having greater 
perceived barriers was found to be associated with a lower 
quality of life. Further research should be conducted focusing 
on groups underrepresented in this study. Additionally, gas-
troenterology offices should develop a network of reliable 
psychotherapists who are available to people with IBD. Finally, 
successful innovations in psychotherapy, like telehealth visits, 
should continue to be researched and promoted.
DATA AVAILABILITY
All data referenced are available in tables and figures 
within the manuscript.
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